Eating yogurt regularly may reduce the long-term risk for a certain type of colon cancer, according to researchers at Mass ...

An enzyme called cyclin-dependent kinase 2 (CDK2) regulates the cell cycle and may have the potential to drive therapeutic ...

Corbus Pharmaceuticals presented Phase 1 data on CRB-701 at ASCO GU, showing safety, tolerability, and responses across multiple tumor types.

In the ongoing battle against triple negative breast cancer, Vanderbilt researchers have uncovered a promising non-invasive ...

One day after Teddi Mellencamp had surgery to remove two tumors from her brain, her estranged husband, Edwin Arroyave, ...

Interrupting signals exchanged between tumors and the nervous system could become a critical pillar of cancer care ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

Their findings? Those who ate more yogurt had a 20% lower risk of colon cancer if their tumors contained Bifidobacterium.

Gut bacteria are to blame for the failure of immune checkpoint therapy for ovarian cancer, new research reveals.

Amgen will continue to advance half of the combo, PRMT5 inhibitor AMG 193, for which it is running a mid-stage trial in ...

LATS1/2-inactivation and consequent nuclear YAP/TAZ hyperactivation in the mammary epithelium drives the development of a pro ...

Teddi Mellencamp’s ex-husband Edwin Arroyave shared an update on her brain cancer surgery after tumors removed ...